ASXL1 and acute myeloid leukemia: To assess whether AML-ASXL1 samples and BOS samples shared DNAm signatures and epigenetic changes, we obtained Illumina 450K DNAm data for AML samples (n = 6) from TCGA on the GDC repository [30, 56].